Rev. Bras. Reumatol. vol.53 número6 en v53n6a09

ABAT, abatecept; ADA, adalimumab; anti-TNF, tumor necrosis factor blocking drugs; RA, rheumatoid arthritis; apoB/apoA, apolipoprotein B/apolipoprotein A; Str., stroke;

1 – Graph showing the percentage of patients with rheumatoid factor or positive or negative anti-CCP antibody, among SSc patients without arthritis, SSc with arthritis, and

Effects of anti-tumor necrosis factor agents for familial Mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment. Akgul

Anticyclic citrullinated peptide antibody and rheumatoid factor in South Tunisian patients with rheumatoid arthritis: association with disease activity and severity. Farid SSh, Azizi

A merecer aprofundamento em posteriores estudos, regista-se o seguinte: no estudo da validade externa da escala, embora as correlações, positivas ou negativas,

Verificou-se que na ausência de Taz1, embora sejam activadas as vias de reparação de DNA, comprovado pela localização nos telómeros de proteínas envolvidas na iniciação desta

Improvement in work place and household productivity for pa- tients with early rheumatoid arthritis treated with adalimumab plus methotrexate: work outcomes and their correlations

Figure 1 - Peripheral red blood cells ( a ), haemoglobin ( b ), hematocrit ( c ) levels and erythrocyte sedimentation rate ( d ) in patients with rheumatoid arthritis (RA) treated